What's in Faculdade de Medicina do ABC's pipeline?

Faculdade de Medicina do ABC has 7 drugs in our index: 4 marketed, 0 filed, 1 in Phase 3, 1 in Phase 2, 1 in Phase 1.

Which companies overlap with Faculdade de Medicina do ABC's portfolio?

Top competitors by shared drug class: Novartis, ATS Clinical Research, Glaukos, Energique, Inc., Eurofarma Laboratorios S.A..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/faculdade-de-medicina-do-abc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-09 · How we verify

Faculdade de Medicina do ABC — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Faculdade de Medicina do ABC pipeline: 4 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

4 marketed 0 filed 1 Phase 3 1 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
multivitamins	multivitamins	marketed	Vitamin C [EPC]		Other
Guarana extract	Guarana extract	marketed
Hormone replacement therapy	Hormone replacement therapy	marketed	Hormone replacement therapy	Estrogen receptor (ER-α, ER-β), Progesterone receptor (PR)	Endocrinology / Women's Health
Selective serotonin reuptake inhibitors	Selective serotonin reuptake inhibitors	marketed	Selective serotonin reuptake inhibitor	Serotonin transporter (SERT)	Psychiatry / Neurology
Placebo of Estrogen	Placebo of Estrogen	phase 3			Endocrinology / Women's Health

Therapeutic area mix

Endocrinology / Women's Health · 2
Other · 1
Psychiatry / Neurology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Novartis · 2 shared drug classes
ATS Clinical Research · 1 shared drug class
Glaukos · 1 shared drug class
Energique, Inc. · 1 shared drug class
Eurofarma Laboratorios S.A. · 1 shared drug class
Exela Pharma · 1 shared drug class
Chi Mei Medical Hospital · 1 shared drug class
ABBVIE · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Faculdade de Medicina do ABC:

Cite this brief

Drug Landscape (2026). Faculdade de Medicina do ABC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/faculdade-de-medicina-do-abc. Accessed 2026-06-09.